alexa Stem cell and progenitor cell transplantation in multiple sclerosis: the discrepancy between neurobiological attraction and clinical feasibility.
Healthcare

Healthcare

Journal of Community Medicine & Health Education

Author(s): Lassmann H

Abstract Share this page

Abstract Recent developments in our understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplantation of such cells. In this review the potential of such an approach is discussed, but it is also highlighted that many aspects regarding its feasibility or safety are currently unresolved. Furthermore, recent findings on the pathogenesis of multiple sclerosis lesions indicate that major problems in this disease rather are related to axonal pathology and neurodegeneration rather than to the absence of oligodendrocyte progenitor cells within the lesions. In light of this complex situation, it is concluded that clinical trials of stem- or progenitor cell transplantation in multiple sclerosis are currently premature. This article was published in J Neurol Sci and referenced in Journal of Community Medicine & Health Education

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 23rd World Nursing and Healthcare Conference
    Jul 10-12, 2017, Golden Tulip Berlin - Hotel Hamburg, Berlin, Germany
  • 10th World Congress on Healthcare & Technologies
    Jul 17-18, 2017, Lisbon, Portugal
  • 30th Nursing and Healthcare Congress
    Aug 21-23, 2017, Toronto, Canada

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords